Financial News

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

H.C. Wainwright Cell Therapy Virtual Conference
Fireside Chat recording available on Tuesday, February 28, 2023 at 7:00 am ET

Inaugural Mizuho Oncology Therapeutics Summit
Panel: Developing & Commercializing Cell Therapy
Date: Monday, March 13, 2023 at 8:00 am
Location: Cadillac Hotel & Beach Club, Miami, FL

Oppenheimer 33rd Annual Virtual Healthcare Conference
Presentation: Monday, March 13, 2023 at 1:20 pm ET

Barclays Global Healthcare Conference
Fireside Chat: Wednesday, March 15, 2023 at 2:05 pm ET
Location: Loews Miami Beach Hotel, Miami, FL

A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here:

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit:


Media & Investors
Sarah Spencer
+1 857-242-6076

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info